Temptations and risks of the esthetic pharmacology: the stimulators of the eyelashes growth

Abstract

In this article it is presents the information about innovation method of the application in the field of esthetic medicine the modern pharmacological drug from the prostaglandins’ group, named BIMATOPROST. Initially, this active substance was widely used in ophthalmological practice for the treatment of primary open-angle glaucoma and for this indication was part of a number of ophthalmological drugs such as Kareprost, Bimat, Lumigan, Xlash and etc. Nowadays, the presented active substance has already begun to be used according to a different indication, mainly for cosmetic purposes - to stimulate the growth of the eyelashes. This was most relevant in those clinical cases where the esthetically patient was not satisfied with the length and thickness of the eyelashes, which could be diagnosed like a hypotrichosis of the eyelashes. In the article also was noticed about the danger of the side effects and risks of such esthetic pharmacology.